Table 3 Clinical Summary in the poor and good motor function group

Age(y)

60.8 ± 11.0

58.3 ± 12.9

0.41

Sex (Male,%)

6(35.3%)

28(32.6%)

0.83

BMI (kg/m²)

26.3 ± 4.6

26.7 ± 4.1

0.71

Diabetes (n,%)

1(5.9%)

12(14%)

0.36

Hypertension (n,%)

17(100%)

82(95.3%)

0.36

SBP (mmHg)

172.4 ± 33.2

180.6 ± 23.3

0.33

DBP (mmHg)

94.3 ± 19.7

106.2 ± 19.3

0.02

GCS

10.0 ± 2.0

9.6 ± 2.2

0.41

Affected side

0.96

  Left

9(52.9%)

46(53.5%)

  Right

8(47.1%)

40(46.5%)

Hematoma volume (ml)

21.2 ± 7.2

34.4 ± 4.2

 < 0.001

Therapy type

0.067

  Surgery

4(23.5%)

41(47.7%)

  Conservative medication

13(76.5%)

45(52.3%)

FMA-WH score at admission

9.2 ± 5.5

4.8 ± 3.5

 < 0.001

BMR score at admission

 < 0.001

  I

3(3.5%)

9(52.9%)

  II

18(20.9%)

7(41.2%)

  III

12(14.0%)

0

  IV

14(16.3%)

1(5.9%)

  V

20(23.3%)

0

  VI

19(22.1%)

0

CAF (ng/mL)

2.5 ± 0.82

4.3 ± 0.72

 < 0.001

S100B (ng/L)

286.6 ± 236.4

571.9 ± 190.8

 < 0.001

NfL (pg/mL)

12.1 ± 10.4

41.5 ± 6.3

 < 0.001